AstraZeneca

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed. 

CEO
Pascal Soriot
CEOPascal Soriot
Employees
94,300
Employees94,300
Headquarters
Cambridge, Cambridgeshire
HeadquartersCambridge, Cambridgeshire
Founded
1913
Founded1913
Employees
94,300
Employees94,300

AZN Key Statistics

Market cap
247.69B
Market cap247.69B
Price-Earnings ratio
29.80
Price-Earnings ratio29.80
Dividend yield
1.90%
Dividend yield1.90%
Average volume
3.78M
Average volume3.78M
High today
$80.09
High today$80.09
Low today
$79.34
Low today$79.34
Open price
$79.59
Open price$79.59
Volume
1.98M
Volume1.98M
52 Week high
$87.68
52 Week high$87.68
52 Week low
$61.24
52 Week low$61.24

AZN News

TipRanks 3h
AstraZeneca’s Phase III Study on Heart Failure Treatment: Market Implications

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

TipRanks 3h
AstraZeneca’s New Vaccine Study Targets Avian Influenza

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

TipRanks 3h
AstraZeneca’s Promising Phase II Study on HCC Treatment: A Closer Look

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

Analyst ratings

86%

of 29 ratings
Buy
86.2%
Hold
13.8%
Sell
0%

More AZN News

TipRanks 3h
AstraZeneca’s Innovative Trial on Liver Fibrosis: A Potential Game-Changer

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

TipRanks 3h
AstraZeneca’s Phase III Study on Advanced Liver Cancer Treatment: Key Updates and Market Impact

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

TipRanks 5h
AstraZeneca’s Promising Hypertension Breakthrough: Analyst Recommends Buy Ahead of Phase III Data Presentation

Analyst Steve Scala of TD Cowen maintained a Buy rating on AstraZeneca, with a price target of $95.00. Elevate Your Investing Strategy: Take advantage of TipRan...

TipRanks 1d
AstraZeneca’s Promising Phase III Study on Volrustomig for Mesothelioma

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

TipRanks 1d
AstraZeneca’s eVOLVE-Cervical Study: A New Hope for High-Risk Cervical Cancer

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

TipRanks 1d
AstraZeneca’s PRECEDE Study: Exploring COPD in Cardiovascular Patients

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

TipRanks 1d
AstraZeneca’s NIAGARA-2 Study: A New Frontier in Bladder Cancer Treatment

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unloc...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.